We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

MINDRAY In-Vitro Diagnostics

As a global leader in in-vitro diagnostics, Mindray provides a wide range of efficient, reliable IVD solutions for la... read more Featured Products: More products

Download Mobile App




Mindray Launches New MC-80 Automated Digital Cell Morphology Analyzer

By LabMedica International staff writers
Posted on 26 Sep 2021
Print article
MC-80 Digital Cell Morphology Analyzer (Image courtesy of Mindray)
MC-80 Digital Cell Morphology Analyzer (Image courtesy of Mindray)

Mindray (Shenzhen, China), a leading global medical solutions provider, has launched the new MC-80 Automated Digital Cell Morphology Analyzer, a revolutionary cell morphology system that provides more clarity, more intelligence and more productivity for morphological analysis.

Combining MC-80, Mindray’s hematology solution is expected to revolutionize the high-end hematology segment. Morphological review of blood cells is a crucial procedure following hematology analysis. Most laboratories need to re-examine more than 30% of their blood samples, but find traditional microscopic review labor-intensive and time-consuming. Automated digital cell morphology analyzers are now available on the market, but providing clear and accurate cell images comparable to the microscope remains a fundamental challenge.

Mindray’s new MC-80 is taking digital morphology analysis to the next level, delivering clearer images which are able to capture abnormalities in more detail. With advanced algorithms, the analyzer enables better identification of different cells with high throughput, resulting in greater productivity. Equipped with advanced multi-layer fusion technology, the MC-80 reproduces the pathological features of cells with clear and authentic images, which helps pathologists to detect abnormal cells more easily and make a quicker diagnosis.

The MC-80 facilitates a smart process and less manual intervention by analyzing the smear in an optimal mode according to the results from hematology analyzers. Its advanced algorithms offer reliable cell pre-classification and pre-characterization, and the high-speed FLY-MODE ensures fast and accurate PLT clump identification. With the remote review function, pathologists are able to review results from multiple locations. The high throughput of 60 samples per hour helps shorten the turnaround time, especially for large-sized laboratories. This greatly enhances diagnostic efficiency and ensures faster delivery of results to patients.

“We have spent eight years developing and optimizing the product by collaborating with over 200 top hospitals worldwide. Meanwhile, we have applied for over 100 patents and solved many problems, some of which had been considered insurmountable in automated digital cell morphology analysis,” said Huan Qi, Director of Clinical Research, Medical Affairs; and Director of Upstream Marketing, IVD, Mindray.

Related Links:

MC-80 launch event
Mindray
 

Gold Member
Turnkey Packaging Solution
HLX
Automated Blood Typing System
IH-500 NEXT
New
Silver Member
Benchtop Image Acquisition Device
Microwell Imager
New
Thyroxine ELISA
T4 ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.